CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C05504 | BRD-K09903493 | BRD-K09903493 | -- | -- | -- | Details |
C05505 | BRD-K09907482 | BRD-K09907482 | -- | -- | PRL-3-inhibitor-I | Details |
C05506 | BRD-K09919985 | BRD-K09919985 | -- | -- | -- | Details |
C05507 | BRD-K09922072 | BRD-K09922072 | -- | -- | -- | Details |
C05508 | BRD-K09922076 | BRD-K09922076 | -- | -- | -- | Details |
C05509 | BRD-K09926293 | BRD-K09926293 | -- | -- | -- | Details |
C05510 | BRD-K09927308 | BRD-K09927308 | -- | -- | -- | Details |
C05511 | BRD-K09929530 | BRD-K09929530 | -- | -- | -- | Details |
C05512 | BRD-K09929560 | BRD-K09929560 | -- | -- | -- | Details |
C05513 | BRD-K09935385 | BRD-K09935385 | -- | -- | -- | Details |
C05514 | BRD-K09936924 | BRD-K09936924 | -- | -- | -- | Details |
C05515 | BRD-K09943620 | BRD-K09943620 | -- | -- | -- | Details |
C05516 | BRD-K09945302 | BRD-K09945302 | -- | -- | -- | Details |
C05517 | BRD-K09951645 | dabrafenib | BRAF | RAF inhibitor | -- | Details |
C05518 | BRD-K09957764 | BRD-K09957764 | -- | -- | -- | Details |
C05519 | BRD-K09960817 | BRD-K09960817 | -- | -- | -- | Details |
C05520 | BRD-K09963420 | saquinavir | -- | -- | -- | Details |
C05521 | BRD-K09964242 | BRD-K09964242 | -- | -- | -- | Details |
C05522 | BRD-K09964916 | BRD-K09964916 | -- | -- | -- | Details |
C05523 | BRD-K09972656 | BRD-K09972656 | -- | -- | -- | Details |
C05524 | BRD-K09973807 | BRD-K09973807 | -- | -- | -- | Details |
C05525 | BRD-K09975370 | BRD-K09975370 | -- | -- | -- | Details |
C05526 | BRD-K09975619 | BRD-K09975619 | -- | -- | -- | Details |
C05527 | BRD-K09977233 | BRD-K09977233 | -- | -- | -- | Details |
C05528 | BRD-K09977695 | BRD-K09977695 | -- | -- | -- | Details |
C05529 | BRD-K09977699 | BRD-K09977699 | -- | -- | -- | Details |
C05530 | BRD-K09989112 | BRD-K09989112 | -- | -- | -- | Details |
C05531 | BRD-K09991945 | BRD-K09991945 | -- | -- | GSK-3-inhibitor-II | Details |
C05532 | BRD-K09993756 | BRD-K09993756 | -- | -- | -- | Details |
C05533 | BRD-K09995054 | BRD-K09995054 | -- | -- | -- | Details |
C05534 | BRD-K09996575 | BRD-K09996575 | -- | -- | -- | Details |
C05535 | BRD-K09997269 | BRD-K09997269 | -- | -- | -- | Details |
C05536 | BRD-K10006632 | BRD-K10006632 | -- | -- | -- | Details |
C05537 | BRD-K10008415 | BRD-K10008415 | -- | -- | -- | Details |
C05538 | BRD-K10010115 | BRD-K10010115 | -- | -- | -- | Details |
C05539 | BRD-K10010414 | BRD-K10010414 | -- | -- | -- | Details |
C05540 | BRD-K10011427 | BRD-K10011427 | -- | -- | -- | Details |
C05541 | BRD-K10013730 | BRD-K10013730 | -- | -- | -- | Details |
C05542 | BRD-K10014225 | BRD-K10014225 | -- | -- | -- | Details |
C05543 | BRD-K10016611 | BRD-K10016611 | -- | -- | pyridine-2-aldoxime | Details |
C05544 | BRD-K10017294 | BRD-K10017294 | -- | -- | -- | Details |
C05545 | BRD-K10027041 | BRD-K10027041 | -- | -- | -- | Details |
C05546 | BRD-K10031593 | BRD-K10031593 | -- | -- | -- | Details |
C05547 | BRD-K10034020 | BRD-K10034020 | -- | -- | -- | Details |
C05548 | BRD-K10042277 | desmethylclozapine | CHRM1; DRD2; DRD3; HTR2A; HTR2C | Acetylcholine receptor agonist | -- | Details |
C05549 | BRD-K10046096 | BRD-K10046096 | -- | -- | -- | Details |
C05550 | BRD-K10048365 | BRD-K10048365 | -- | -- | -- | Details |
C05551 | BRD-K10054282 | BRD-K10054282 | -- | -- | -- | Details |
C05552 | BRD-K10055064 | BRD-K10055064 | -- | -- | -- | Details |
C05553 | BRD-K10055851 | BRD-K10055851 | -- | -- | -- | Details |
C05554 | BRD-K10057859 | BRD-K10057859 | -- | -- | -- | Details |
C05555 | BRD-K10058823 | BRD-K10058823 | -- | -- | -- | Details |
C05556 | BRD-K10062203 | BRD-K10062203 | -- | -- | -- | Details |
C05557 | BRD-K10064333 | BRD-K10064333 | -- | -- | -- | Details |
C05558 | BRD-K10065684 | dantron | -- | -- | -- | Details |
C05559 | BRD-K10071630 | ertugliflozin | SLC5A2 | Sodium/glucose cotransporter inhibitor | -- | Details |
C05560 | BRD-K10081616 | BRD-K10081616 | -- | -- | -- | Details |
C05561 | BRD-K10082717 | BRD-K10082717 | -- | -- | -- | Details |
C05562 | BRD-K10087454 | BRD-K10087454 | -- | -- | -- | Details |
C05563 | BRD-K10087503 | BRD-K10087503 | -- | -- | -- | Details |
C05564 | BRD-K10089296 | BRD-K10089296 | -- | -- | -- | Details |
C05565 | BRD-K10092312 | BRD-K10092312 | -- | -- | -- | Details |
C05566 | BRD-K10098805 | rhapontin | -- | -- | -- | Details |
C05567 | BRD-K10103010 | methyl-salicylate | -- | -- | -- | Details |
C05568 | BRD-K10105458 | BRD-K10105458 | -- | -- | -- | Details |
C05569 | BRD-K10108893 | BRD-K10108893 | -- | -- | -- | Details |
C05570 | BRD-K10114046 | BRD-K10114046 | -- | -- | -- | Details |
C05571 | BRD-K10120618 | BRD-K10120618 | -- | -- | -- | Details |
C05572 | BRD-K10130686 | BRD-K10130686 | -- | -- | -- | Details |
C05573 | BRD-K10133810 | BRD-K10133810 | -- | -- | -- | Details |
C05574 | BRD-K10134498 | BRD-K10134498 | -- | -- | -- | Details |
C05575 | BRD-K10135449 | BRD-K10135449 | -- | -- | -- | Details |
C05576 | BRD-K10136726 | BRD-K10136726 | -- | -- | tosyllysyl-chloromethyl-ketone | Details |
C05577 | BRD-K10143126 | BRD-K10143126 | -- | -- | -- | Details |
C05578 | BRD-K10144853 | BRD-K10144853 | -- | -- | -- | Details |
C05579 | BRD-K10146653 | BRD-K10146653 | -- | -- | -- | Details |
C05580 | BRD-K10148216 | BRD-K10148216 | -- | -- | -- | Details |
C05581 | BRD-K10157835 | BRD-K10157835 | -- | -- | -- | Details |
C05582 | BRD-K10160311 | BRD-K10160311 | -- | -- | -- | Details |
C05583 | BRD-K10170503 | BRD-K10170503 | -- | -- | -- | Details |
C05584 | BRD-K10171338 | BRD-K10171338 | -- | -- | -- | Details |
C05585 | BRD-K10176267 | L-701252 | GRIN1 | Glutamate receptor antagonist | -- | Details |
C05586 | BRD-K10176883 | BRD-K10176883 | -- | -- | -- | Details |
C05587 | BRD-K10177585 | PSB-11 | ADORA3 | Adenosine receptor antagonist | -- | Details |
C05588 | BRD-K10178088 | BRD-K10178088 | -- | -- | -- | Details |
C05589 | BRD-K10180294 | uracil-mustard | -- | -- | -- | Details |
C05590 | BRD-K10180613 | BRD-K10180613 | -- | -- | -- | Details |
C05591 | BRD-K10181552 | BRD-K10181552 | -- | -- | -- | Details |
C05592 | BRD-K10182289 | BRD-K10182289 | -- | -- | -- | Details |
C05593 | BRD-K10182851 | BRD-K10182851 | -- | -- | -- | Details |
C05594 | BRD-K10189430 | BRD-K10189430 | -- | -- | -- | Details |
C05595 | BRD-K10191318 | BRD-K10191318 | -- | -- | -- | Details |
C05596 | BRD-K10196668 | BRD-K10196668 | -- | -- | -- | Details |
C05597 | BRD-K10207760 | lasalocid | -- | -- | -- | Details |
C05598 | BRD-K10210954 | BRD-K10210954 | -- | -- | -- | Details |
C05599 | BRD-K10211010 | BRD-K10211010 | -- | -- | -- | Details |
C05600 | BRD-K10211218 | BRD-K10211218 | -- | -- | -- | Details |
C05601 | BRD-K10221669 | BRD-K10221669 | -- | -- | -- | Details |
C05602 | BRD-K10225413 | BRD-K10225413 | -- | -- | -- | Details |
C05603 | BRD-K10225826 | BRD-K10225826 | -- | -- | -- | Details |